Developer docs
API playgroundTry for free, no card

Search company profiles

Lochness Medical Supplies

Full company profile

uuid000al46

Namestring
Lochness Medical Supplies
Legal namestring
Lochness Medical Supplies Inc.
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Lochness Medical Supplies Inc. is a privately held US distributor of Rapid Response™ point-of-care diagnostic tests, headquartered in Buffalo, NY and operating under Ontario governing law. Founded in 2011, the company distributes products manufactured by BTNX Inc. across all 50 US states and into Canada, serving staffing agencies, addiction treatment centers, physician offices, diagnostic laboratories, harm reduction organizations, government health authorities, educational institutions, and individual consumers. Its portfolio spans drug screening (multi-drug saliva cups, urine cups with vacuum lids), harm reduction testing (fentanyl, xylazine, medetomidine, benzodiazepine, nitazene strips), spiked-drink detection (GHB cards), infectious disease (COVID-19 antigen tests), urinalysis, fertility testing, cancer screening (Fecal Immunochemical Test), alcohol testing, and medical accessories. Most products are based on rapid lateral flow immunoassay technology with results delivered in 1–10 minutes; the company also offers the RapidReader App for automated result interpretation and the RapidRemote AI-powered virtual proctoring service for remote supervised drug screening. Manufacturing is conducted in ISO 13485:2016 MDSAP and ISO 9001:2008 certified facilities, with regulatory clearances from FDA (EUA), Health Canada, CE Mark, and CLIA Waived status; harm reduction products are independently validated by Johns Hopkins Bloomberg School of Public Health and Ghent University. The revenue model combines unit-based consumables sales with two subscription-style services (RapidRemote and RapidReader App), distributed through an e-commerce storefront, B2B/enterprise sales with account management, and the broader BTNX distribution network. The company employs 11–50 people, has raised no disclosed outside funding, and reports no publicly available revenue figures.

Short descriptiontext

Lochness Medical Supplies is a US distributor of Rapid Response™ point-of-care diagnostics, serving staffing agencies, treatment centers, harm reduction programs, and clinics with drug screening, infectious disease, and harm reduction tests manufactured by BTNX Inc.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBuffalo, United States
HQ citystring
Buffalo
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
point of care diagnostics, rapid diagnostic testing, drug screening supplies, harm reduction testing, medical device distribution
Industry3 codes
1Microbiology & Infectious Disease Testing (Trial Support)
CodeHLAGAEAFPrimaryYes
2Sample Logistics, Biorepository & IVD Kit Management (Trial Support)
CodeHLAGAEAIPrimaryNo
3Molecular & Genetic Testing (PCR/NGS/qPCR)
CodeHLAGADAFPrimaryNo
NAICS code3 codes
  • Medical and Diagnostic Laboratories62151
  • Testing Laboratories and Services541380
  • Other Scientific and Technical Consulting Services541690
SIC code3 codes
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Services-Medical Laboratories8071
  • Laboratory Analytical Instruments3826
Product category
Point-of-Care Diagnostics Distribution
No data
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Diagnostic Test Products Sales
TypeOne Time License
Description

Revenue generated from sale of Rapid Response™ point-of-care diagnostic tests including drug screening, infectious diseases, women's health, urinalysis, and cancer screening products. Products sold in various kit sizes and configurations with per-unit pricing.

lochnessmedical.com
2Medical Accessories Sales
TypeOne Time License
Description

Sale of consumables and accessories required for rapid testing including urine specimen cups, gloves, lancets, nasal aspirate specimen traps, vacuum transfer tubes, and masks.

lochnessmedical.com
3RapidRemote Proctoring Service
TypeSubscription Recurring
Description

Virtual proctoring service subscription enabling remote drug screening with AI-powered monitoring and documentation. Integrates with customer ATS/EMR/EHR systems.

lochnessmedical.com
4RapidReader App Software
TypeSubscription Recurring
Description

Software service for automated test result interpretation and database upload. Streamlines workflow for organizations performing drug screening.

lochnessmedical.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Marketing or Sales, Technology or R&D, Personnel, Infrastructure
Pricing details5 tiers
1COVID-19 Antigen Test OTC
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$4.00 per 1 Test/Kit (OTC, at-home use)

lochnessmedical.com
2COVID-19 Antigen Test POC
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$100.00 per 25 Tests/Kit (Point-of-Care use)

lochnessmedical.com
3Benzodiazepine Test Strips
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$75.00 per 100 Tests/Kit

lochnessmedical.com
4Nitazene Test Strips
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$180.00 per 100 Tests/Kit

lochnessmedical.com
5Spiked Drink Test GHB
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$7.99 per 2 Pack (8 total tests, 4 per card)

lochnessmedical.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Rapid Response
Description

The Rapid Response brand guarantees quality and value for the medical device market. Products are CE Marked and approved under FDA, Health Canada, and other regulatory bodies around the world.

lochnessmedical.com
Core offering1 text field

Lochness Medical Supplies Inc. is a premier US distribution company for the Rapid Response™ brand of point-of-care diagnostic tests, including drug screening (urine and saliva), harm reduction strips (fentanyl, xylazine, medetomidine, benzodiazepine, nitazene), infectious disease tests (COVID-19, Strep A, RSV, H. pylori), urinalysis, fertility testing, and colorectal cancer screening (FIT). The company also offers clinical, procedural, and financial consulting services to healthcare providers and runs the AI-powered RapidRemote virtual proctoring service and the RapidReader App for automated workflow.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 98.0% accuracy for Fecal Immunochemical Test (FIT) in detecting colorectal cancer indicators
+3 more records
Product overview1 text field

Lochness Medical Supplies Inc. is a premier distribution company carrying Rapid Response™ point of care diagnostics in the United States. Their product portfolio encompasses harm reduction testing (Fentanyl, Xylazine, Medetomidine, Benzodiazepine, and Nitazene test strips), drug screening solutions (multi-drug saliva test cups, urine cups with vacuum lids, ESA tests), alcohol testing (saliva and urine), spiked drink detection (GHB detection cards), infectious disease testing (COVID-19 antigen tests), urinalysis products, fertility testing, cancer screening (Fecal Immunochemical Test/FIT kits), and medical accessories (specimen cups, gloves, lancets, transfer tubes). The company offers the RapidRemote virtual proctoring service for remote drug screening and the RapidReader App for automated result capture. Products are manufactured by BTNX Inc. and distributed under the Rapid Response™ brand with ISO certifications and regulatory approvals from FDA, Health Canada, and CE marking.

Product and service1 record
1Rapid Response™ Fentanyl Test Strip
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

BTNX Inc. is the manufacturer of Rapid Response™ brand products. Lochness Medical serves as the US distribution partner for BTNX products. BTNX holds ISO 13485:2016 MDSAP certification for manufacturing and develops products including drug screening tests, infectious disease tests, and diagnostic devices. Products are distributed globally to thousands of customers.

Strategic tierMinorTypeOthers
Description

Vancouver Coastal Health Authority distributes Rapid Response™ Fentanyl Test Strips at overdose prevention sites, supervised consumption sites, and in take-home drug testing kits in British Columbia, Canada. Represents adoption of products for harm reduction public health initiatives.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Johns Hopkins Bloomberg School of Public Health conducted independent evaluation of BTNX Rapid Response Fentanyl Test Strips. Study found BTNX strips showed lowest detection limit and highest accuracy among fentanyl detection methods tested. Validated product for harm reduction drug checking purposes.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Ghent University conducted research validating BTNX Rapid Response Nitazene Test Strips. Study confirmed strips are capable of detecting wide range of nitazene analogues in authentic street drug samples, supporting harm reduction applications.

Strategic tierMinorTypeOthers
Description

Third-party quality assurance and testing certification organization. Products manufactured in facilities certified by Intertek as conforming to ISO quality management standards.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

California legislation (AB-1524) requires state universities and community colleges to stock drug testing devices including fentanyl test strips. Products distributed to campus health centers for harm reduction purposes.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Specialty diagnostics company offering rapid point-of-care tests including oral fluid drug screening (Intercept) and infectious disease testing - directly competes in Lochness's saliva-based drug screening and POC infectious disease categories.

TypeDirect peer
Description

Manufacturer of the Rapid Response brand products that Lochness distributes in the US. Also serves as a direct distributor in the Canadian market, operating the same product portfolio under identical regulatory certifications.

TypeBroad incumbent
Description

Major medical supply distributor serving physician offices, occupational health, and clinical laboratories with POC diagnostics and drug testing products as part of a broader medical supply catalog.

TypeDirect peer
Description

US-based distributor and manufacturer of rapid drug screening tests and point-of-care diagnostics serving workplace, clinical, and treatment center markets - directly comparable product portfolio and customer segments.

TypeBroad incumbent
Description

Largest US medical-surgical distributor with a broad portfolio that includes POC diagnostic tests, drug screening supplies, and harm reduction products - competes for the same physician office and clinical customer accounts with greater scale.

TypeBroad incumbent
Description

Large medical products distributor offering laboratory and POC diagnostic supplies to healthcare providers and laboratories, competing for institutional customers in the same drug screening and clinical diagnostics verticals.

TypeDirect peer
Description

US-based distributor specializing in CLIA-waived point-of-care diagnostic tests to physician offices, occupational health, and workplace drug screening markets - directly comparable distribution model and customer base.

TypeDirect peer
Description

Major rapid diagnostics manufacturer and distributor offering Sofia-platform rapid antigen tests for infectious diseases (COVID, Strep, RSV) and other POC diagnostics that compete directly with Rapid Response products.

TypeDirect peer
Description

Smaller specialty distributor of rapid drug screening products and harm reduction test strips, often serving treatment centers and staffing agencies - directly comparable niche distribution model.

TypeBroad incumbent
Description

Global diagnostics leader manufacturing and distributing the Binax rapid test platform and other POC products that compete with Rapid Response infectious disease tests while offering broader institutional support.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Lochness Medical Supplies

Point-of-Care Diagnostics Distributionlochnessmedical.com

Lochness Medical Supplies is a US distributor of Rapid Response™ point-of-care diagnostics, serving staffing agencies, treatment centers, harm reduction programs, and clinics with drug screening, infectious disease, and harm reduction tests manufactured by BTNX Inc.

What Lochness Medical Supplies does

Lochness Medical Supplies Inc. is a privately held US distributor of Rapid Response™ point-of-care diagnostic tests, headquartered in Buffalo, NY and operating under Ontario governing law. Founded in 2011, the company distributes products manufactured by BTNX Inc. across all 50 US states and into Canada, serving staffing agencies, addiction treatment centers, physician offices, diagnostic laboratories, harm reduction organizations, government health authorities, educational institutions, and individual consumers. Its portfolio spans drug screening (multi-drug saliva cups, urine cups with vacuum lids), harm reduction testing (fentanyl, xylazine, medetomidine, benzodiazepine, nitazene strips), spiked-drink detection (GHB cards), infectious disease (COVID-19 antigen tests), urinalysis, fertility testing, cancer screening (Fecal Immunochemical Test), alcohol testing, and medical accessories. Most products are based on rapid lateral flow immunoassay technology with results delivered in 1–10 minutes; the company also offers the RapidReader App for automated result interpretation and the RapidRemote AI-powered virtual proctoring service for remote supervised drug screening. Manufacturing is conducted in ISO 13485:2016 MDSAP and ISO 9001:2008 certified facilities, with regulatory clearances from FDA (EUA), Health Canada, CE Mark, and CLIA Waived status; harm reduction products are independently validated by Johns Hopkins Bloomberg School of Public Health and Ghent University. The revenue model combines unit-based consumables sales with two subscription-style services (RapidRemote and RapidReader App), distributed through an e-commerce storefront, B2B/enterprise sales with account management, and the broader BTNX distribution network. The company employs 11–50 people, has raised no disclosed outside funding, and reports no publicly available revenue figures.

Lochness Medical Supplies firmographics

Firmographics
Name
Lochness Medical Supplies
Legal name
Lochness Medical Supplies Inc.
Website
https://lochnessmedical.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
11–50 employees
Short description
Lochness Medical Supplies is a US distributor of Rapid Response™ point-of-care diagnostics, serving staffing agencies, treatment centers, harm reduction programs, and clinics with drug screening, infectious disease, and harm reduction tests manufactured by BTNX Inc.
Ownership category
akta.pro rank

Lochness Medical Supplies industry classification

Industry
Product category
Point-of-Care Diagnostics Distribution
NAICS
Medical and Diagnostic Laboratories (62151), Testing Laboratories and Services (541380), Other Scientific and Technical Consulting Services (541690)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Services-Medical Laboratories (8071), Laboratory Analytical Instruments (3826)
akta.pro primary industry
Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF)
akta.pro secondary industries
Sample Logistics, Biorepository & IVD Kit Management (Trial Support) (HLAGAEAI), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

Keywords

  • Point of care diagnostics
  • Rapid diagnostic testing
  • Drug screening supplies
  • Harm reduction testing
  • Medical device distribution

Where Lochness Medical Supplies is headquartered

Location

Headquarters

HQ city
Buffalo
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Lochness Medical Supplies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Marketing or Sales, Technology or R&D, Personnel, Infrastructure

Revenue model

  1. Diagnostic Test Products Sales: Revenue generated from sale of Rapid Response™ point-of-care diagnostic tests including drug screening, infectious diseases, women's health, urinalysis, and cancer screening products. Products sold in various kit sizes and configurations with per-unit pricing.
  2. Medical Accessories Sales: Sale of consumables and accessories required for rapid testing including urine specimen cups, gloves, lancets, nasal aspirate specimen traps, vacuum transfer tubes, and masks.
  3. RapidRemote Proctoring Service: Virtual proctoring service subscription enabling remote drug screening with AI-powered monitoring and documentation. Integrates with customer ATS/EMR/EHR systems.
  4. RapidReader App Software: Software service for automated test result interpretation and database upload. Streamlines workflow for organizations performing drug screening.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goCOVID-19 Antigen Test OTC
Unit PricingPay-as-you-goCOVID-19 Antigen Test POC
Unit PricingPay-as-you-goBenzodiazepine Test Strips
Unit PricingPay-as-you-goNitazene Test Strips
Unit PricingPay-as-you-goSpiked Drink Test GHB

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Lochness Medical Supplies product offering

Product offering

Core offering

Lochness Medical Supplies Inc. is a premier US distribution company for the Rapid Response™ brand of point-of-care diagnostic tests, including drug screening (urine and saliva), harm reduction strips (fentanyl, xylazine, medetomidine, benzodiazepine, nitazene), infectious disease tests (COVID-19, Strep A, RSV, H. pylori), urinalysis, fertility testing, and colorectal cancer screening (FIT). The company also offers clinical, procedural, and financial consulting services to healthcare providers and runs the AI-powered RapidRemote virtual proctoring service and the RapidReader App for automated workflow.

Product overview

Lochness Medical Supplies Inc. is a premier distribution company carrying Rapid Response™ point of care diagnostics in the United States. Their product portfolio encompasses harm reduction testing (Fentanyl, Xylazine, Medetomidine, Benzodiazepine, and Nitazene test strips), drug screening solutions (multi-drug saliva test cups, urine cups with vacuum lids, ESA tests), alcohol testing (saliva and urine), spiked drink detection (GHB detection cards), infectious disease testing (COVID-19 antigen tests), urinalysis products, fertility testing, cancer screening (Fecal Immunochemical Test/FIT kits), and medical accessories (specimen cups, gloves, lancets, transfer tubes). The company offers the RapidRemote virtual proctoring service for remote drug screening and the RapidReader App for automated result capture. Products are manufactured by BTNX Inc. and distributed under the Rapid Response™ brand with ISO certifications and regulatory approvals from FDA, Health Canada, and CE marking.

Differentiator

Problem solved

Functional benefit

Brands

  • Rapid Response: The Rapid Response brand guarantees quality and value for the medical device market. Products are CE Marked and approved under FDA, Health Canada, and other regulatory bodies around the world.

Products and services

  • Rapid Response™ Fentanyl Test Strip

Quantifiable outcome

  • 98.0% accuracy for Fecal Immunochemical Test (FIT) in detecting colorectal cancer indicators
  • +3 more outcomes

Companies that use Lochness Medical Supplies

Customer profile

Named customers6 records

Segments7 records

Lochness Medical Supplies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability2 records

Feature5 records

Lochness Medical Supplies partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • BTNX Inc.coreStrategic or Co-development PartnerBTNX Inc. is the manufacturer of Rapid Response™ brand products. Lochness Medical serves as the US distribution partner for BTNX products. BTNX holds ISO 13485:2016 MDSAP certification for manufacturing and develops products including drug screening tests, infectious disease tests, and diagnostic devices. Products are distributed globally to thousands of customers.
  • Vancouver Coastal Health AuthorityminorOthersVancouver Coastal Health Authority distributes Rapid Response™ Fentanyl Test Strips at overdose prevention sites, supervised consumption sites, and in take-home drug testing kits in British Columbia, Canada. Represents adoption of products for harm reduction public health initiatives.
  • Johns Hopkins Bloomberg School of Public HealthcoreStrategic or Co-development PartnerJohns Hopkins Bloomberg School of Public Health conducted independent evaluation of BTNX Rapid Response Fentanyl Test Strips. Study found BTNX strips showed lowest detection limit and highest accuracy among fentanyl detection methods tested. Validated product for harm reduction drug checking purposes.
  • Ghent University Laboratory of ToxicologycoreStrategic or Co-development PartnerGhent University conducted research validating BTNX Rapid Response Nitazene Test Strips. Study confirmed strips are capable of detecting wide range of nitazene analogues in authentic street drug samples, supporting harm reduction applications.
  • IntertekminorOthersThird-party quality assurance and testing certification organization. Products manufactured in facilities certified by Intertek as conforming to ISO quality management standards.
  • California Postsecondary InstitutionsminorChannel Partner/ Reseller/ DistributorCalifornia legislation (AB-1524) requires state universities and community colleges to stock drug testing devices including fentanyl test strips. Products distributed to campus health centers for harm reduction purposes.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Lochness Medical Supplies competitors and assessment

Company assessment

Direct peers

  • OraSure Technologies: Specialty diagnostics company offering rapid point-of-care tests including oral fluid drug screening (Intercept) and infectious disease testing - directly competes in Lochness's saliva-based drug screening and POC infectious disease categories.
  • BTNX Inc. Manufacturer of the Rapid Response brand products that Lochness distributes in the US. Also serves as a direct distributor in the Canadian market, operating the same product portfolio under identical regulatory certifications.
  • Premier Biotech: US-based distributor and manufacturer of rapid drug screening tests and point-of-care diagnostics serving workplace, clinical, and treatment center markets - directly comparable product portfolio and customer segments.
  • CLIAwaived Inc. US-based distributor specializing in CLIA-waived point-of-care diagnostic tests to physician offices, occupational health, and workplace drug screening markets - directly comparable distribution model and customer base.
  • QuidelOrtho: Major rapid diagnostics manufacturer and distributor offering Sofia-platform rapid antigen tests for infectious diseases (COVID, Strep, RSV) and other POC diagnostics that compete directly with Rapid Response products.
  • Drug Testing Solutions: Smaller specialty distributor of rapid drug screening products and harm reduction test strips, often serving treatment centers and staffing agencies - directly comparable niche distribution model.

Broad incumbents

  • Henry Schein Medical: Major medical supply distributor serving physician offices, occupational health, and clinical laboratories with POC diagnostics and drug testing products as part of a broader medical supply catalog.
  • McKesson Medical-Surgical: Largest US medical-surgical distributor with a broad portfolio that includes POC diagnostic tests, drug screening supplies, and harm reduction products - competes for the same physician office and clinical customer accounts with greater scale.
  • Cardinal Health Medical Products: Large medical products distributor offering laboratory and POC diagnostic supplies to healthcare providers and laboratories, competing for institutional customers in the same drug screening and clinical diagnostics verticals.
  • Abbott Point of Care: Global diagnostics leader manufacturing and distributing the Binax rapid test platform and other POC products that compete with Rapid Response infectious disease tests while offering broader institutional support.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Lochness Medical Supplies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Lochness Medical Supplies leadership team

Management profile

Number of profiles

Profiles1 record

Lochness Medical Supplies funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Lochness Medical Supplies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lochness Medical Supplies

What does Lochness Medical Supplies do?

Lochness Medical Supplies Inc. is a premier US distribution company for the Rapid Response™ brand of point-of-care diagnostic tests, including drug screening (urine and saliva), harm reduction strips (fentanyl, xylazine, medetomidine, benzodiazepine, nitazene), infectious disease tests (COVID-19, Strep A, RSV, H. pylori), urinalysis, fertility testing, and colorectal cancer screening (FIT). The company also offers clinical, procedural, and financial consulting services to healthcare providers and runs the AI-powered RapidRemote virtual proctoring service and the RapidReader App for automated workflow.

Is Lochness Medical Supplies a public or private company?

Lochness Medical Supplies is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Lochness Medical Supplies founded?

Lochness Medical Supplies was founded in 2011. It employs 11 to 50 people.

Where is Lochness Medical Supplies based?

Lochness Medical Supplies is headquartered in Buffalo, United States, in the North America region.

How does Lochness Medical Supplies make money?

Four revenue lines are on record. Diagnostic Test Products Sales are the primary driver. The others are medical Accessories Sales, rapidRemote Proctoring Service and rapidReader App Software.

Who are Lochness Medical Supplies's main competitors?

Direct peers on record are OraSure Technologies, BTNX Inc., Premier Biotech, CLIAwaived Inc., QuidelOrtho and Drug Testing Solutions. Broad incumbents are Henry Schein Medical, McKesson Medical-Surgical, Cardinal Health Medical Products and Abbott Point of Care.

Does Lochness Medical Supplies have an API?

No public API is recorded for Lochness Medical Supplies.

What industry is Lochness Medical Supplies in?

Lochness Medical Supplies's product category is Point-of-Care Diagnostics Distribution. Its primary akta.pro industry code is HLAGAEAF, Microbiology & Infectious Disease Testing (Trial Support), with a secondary code of HLAGAEAI, Sample Logistics, Biorepository & IVD Kit Management (Trial Support). Its NAICS code is 62151 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales